Reduction of Cisplatin Nephrotoxicity by Selenium: Does Metallothionein Play a Role?
Cisplatin is an important antineoplastic drug widely used against several tumors, especially those of the testis and ovaries (Prestayko et al. 1980). The dose-limiting side-effect of cisplatin chemotherapy is its nephrotoxicity, mainly consisting of degeneration of proximal tubules (Walker and Gale 1981); the mechanism of this nephrotoxicity is still unknown. Many attempts have been made to reduce cisplatin-induced nephrotoxicity. An interesting approach in this respect is the use of selenium. Selenium has been shown to prevent cadmium toxicity in animals (Parizek et al. 1974) and a protective effect of selenium against cisplatin lethality in mice has been described (Berry et al. 1984). It is not known how selenium exerts its protective effect against cisplatin.
KeywordsSodium Selenite Kidney Damage Copper Acetate Blood Urea Nitrogen Level Trace Element Metabolism
Unable to display preview. Download preview PDF.
- Baldew GS, Van den Hamer CJA, de Goeij JJM, McVie JG (1987) Selenium-induced protection against cis-diamminedichloroplatinum (II) nephrotoxicity in mice and rats. (Manuscript in preparation)Google Scholar
- Hoeschele JD, Butler TA, Roberts JA (1982) Analysis and refinement of the microscale synthesis of the 195mPt-labeled antitumor drug, cis-dichlorodiammineplatinum (II), cis-DDP. Radiochim Acta 31:27–36Google Scholar
- Parizek J, Kalouskova J, Baliky A, Benes J, Pavlik L (1974) Interaction of selenium with mercury, cadmium and other toxic metals. In: Hoekstra WC, Suttie JW, Ganther HE, Mertz W (eds) Trace element metabolism in animals, vol. 2. University Park Press, Baltimore, pp 119–132Google Scholar
- Prestayko AW, Crooke ST, Carter SK (eds) (1980) Cisplatin: current status and new developments. Academic, New YorkGoogle Scholar